C-RAD AB – Consolidated Year-End report January-December 2019 - Seite 3
Organization
To fully capitalize on the opportunities in North America C-RAD announced the recruitment of Brian Loar for the role President C-RAD North America. Brian is in charge of our business through our
direct sales organization and newly established partnership with Elekta. Brian has a more than 20 years of experience within the radiation therapy business in North America. He is joining C-RAD
from a position as Vice President Sales, North America at Varian Medical Systems.
We remain confident about our market opportunity and are convinced that C-RAD is in a good position to outgrow the market. We have a fantastic team, excited customers and great products that allow us to enable our customers to implement high precision radiation therapy to the benefit of their patients.
About C-RAD
C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com
Lesen Sie auch
This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication at 08:30 CET on January 31, 2020.
Attachment